AstraZeneca Aktie
| 165,40EUR | -1,45EUR | -0,87% |
WKN: 886455 / ISIN: GB0009895292
Diese Analysten bewerten die AstraZeneca-Aktie
| Analyst | Buy | Hold | Sell | Kursziel | Abstand | Datum |
|---|---|---|---|---|---|---|
| Jefferies & Company Inc. | 180,00£ | 25,17% | 06.03.26 | |||
| Deutsche Bank AG | 115,00£ | -20,03% | 05.03.26 | |||
| JP Morgan Chase & Co. | 151,10£ | 5,08% | 02.03.26 | |||
| UBS AG | 176,00£ | 22,39% | 26.02.26 | |||
| Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | 1,70£ | -98,82% | 18.02.26 | |||
| Bernstein Research | 205,00£ | 42,56% | 13.02.26 | |||
| Barclays Capital | 165,00£ | 14,74% | 11.02.26 | |||
| Goldman Sachs Group Inc. | 163,89£ | 13,97% | 28.01.26 |
Historische Rating-Entwicklung
|
0
Buy
0
Hold
0
Sell
Aktuell
|
0
Buy
0
Hold
0
Sell
vor 1/2 Jahr
|
0
Buy
0
Hold
0
Sell
vor 1 Jahr
|